PharmaIN Corporation
  • ABOUT
    • MANAGEMENT TEAM
    • INVESTMENT PARTNERS
  • DISEASE TARGETS
    • PIPELINE
    • LIVER CIRRHOSIS
    • ONCOLOGY
  • FOR PATIENTS
    • CLINICAL TRIAL
  • FOR PARTNERS
  • CAREERS
  • CONTACT US

For Partners

FOR PARTNERS

PharmaIN is actively seeking collaboration, licensing, and investment opportunities.
For more information, please send inquiries to:

ContactUs@pharmain.com

Upcoming Events

AASLD

San Diego, CA – November 15-19, 2024

PHIN-214 Poster Presentation

Presentations

  • PHIN-214 Poster Presentation: AASLD
  • PharmaIN Company Overview
  • PHIN-214 Overview

Publications

  • [PHIN-214] Biomedicine and Pharmacotherapy Preclinical Publication
  • [PHIN-1314] Science Translational Medicine Publication

PharmaIN Press Releases

  • PRWeb: PharmaIN Unveils Interim Phase 1b Clinical Data on Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - The Liver Meeting 2024
  • PRWeb: PharmaIN Announces Acceptance of Abstract for Poster Presentation at AASLD, The Liver Meeting 2024
  • PRWeb: The Publication of Research in Science Translational Medicine Announcement
  • PharmaIN and Shionogi Announcement

PharmaIN - in the news

  • Penn Today: A modified peptide shows promise for fighting tumors

CONTACT US

ContactUs@pharmain.com
Phone: +1 206 568 1450

PharmaIN Corporation
11812 North Creek Parkway N. Suite #101
Bothell, WA 98011

HOME
ABOUT
DISEASE TARGETS
FOR PATIENTS
FOR PARTNERS
CAREERS

FINANCIAL CONFLICT
OF INTEREST POLICY

Sign up to receive PharmaIN updates

Copyright © 2023 PharmaIN Corp | ALL RIGHTS RESERVED